Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: fluorine F 18 DCFPyLFind trials that include: Any drugs shown Results 1-6 of 6 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer (OSPREY) Status: ActivePhase: Phase III, Phase IIType: DiagnosticAge: 18 and overTrial IDs: PyL 2301, NCI-2017-00029, NCT02981368 2. Stereotactic Body Radiation Therapy in Treating Patients with Prostate Cancer That Has Spread to the Bone or Soft Tissue Status: ActivePhase: Phase IIType: TreatmentAge: 18 to 100Trial IDs: J15180, NCI-2016-00693, CRMS-62604, IRB00079078, NCT02680587 3. Fluorine F 18 DCFPyL PET/CT in Imaging Patients with High Risk or Relapsed Prostate Cancer Status: ActivePhase: Phase IIType: DiagnosticAge: 18 and overTrial IDs: 17-C-0109, NCI-2017-01052, P152544, NCT03181867 4. Fluorine F 18 DCFPy PET/CT in Imaging Patients with Metastatic or Locally Advanced Prostate Cancer Status: ActivePhase: Phase IType: Biomarker/Laboratory analysis, DiagnosticAge: 18 and overTrial IDs: J1418, NCI-2014-01277, NA_00092956, NCT02151760 5. Fluorine F 18 DCFPyL PET/CT in Imaging Patients with Prostate Cancer Status: ActivePhase: No phase specifiedType: Biomarker/Laboratory analysis, DiagnosticAge: 18 and overTrial IDs: J15216, NCI-2016-00953, CRMS-62968, IRB00084971, NCT02825875 6. 18F-DCFPyL PET/CT in Monitoring Treatment Response in Patients with Metastatic Castration-Resistant Prostate Cancer Status: ActivePhase: No phase specifiedType: Biomarker/Laboratory analysis, DiagnosticAge: 18 and overTrial IDs: J15232, NCI-2016-01248, CRMS-63060, IRB00082289, NCT02856100 Select All on Page Start Over
